These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23755402)

  • 21. Successful switch from clozapine to aripiprazole: a case report.
    Jong-Yih L
    J Clin Psychopharmacol; 2009 Feb; 29(1):93-5. PubMed ID: 19142120
    [No Abstract]   [Full Text] [Related]  

  • 22. Partial agonists in schizophrenia.
    Cousins DA; Young AH
    Br J Psychiatry; 2005 Apr; 186():354. PubMed ID: 15802697
    [No Abstract]   [Full Text] [Related]  

  • 23. Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
    Stern RG; Petti TA; Bopp K; Tobia A
    J Clin Psychopharmacol; 2009 Jun; 29(3):206-9. PubMed ID: 19440071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of aripiprazole in early onset schizophrenia: safety and efficacy.
    Normala I; Hamidin A
    Med J Malaysia; 2009 Sep; 64(3):240-1. PubMed ID: 20527278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Aripiprazole in treatment resistant schizophrenia.
    Hughes D; Morcos M
    J Psychopharmacol; 2008 Nov; 22(8):927-8. PubMed ID: 18308805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 29. Partial agonism and schizophrenia.
    Bolonna AA; Kerwin RW
    Br J Psychiatry; 2005 Jan; 186():7-10. PubMed ID: 15630117
    [No Abstract]   [Full Text] [Related]  

  • 30. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 31. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
    Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W
    Curr Med Res Opin; 2007 Oct; 23(10):2313-23. PubMed ID: 17706003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The patient with schizophrenia taking aripiprazole: case report.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Dec; 17(3-4):234-5. PubMed ID: 16392433
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium.
    Gagliano A; Masi G
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):595-8. PubMed ID: 19877988
    [No Abstract]   [Full Text] [Related]  

  • 34. Aripiprazole-related body-weight gain and nutritional counseling.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E44-5. PubMed ID: 21677226
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
    Freeman B; Levy W; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases.
    Voros V; Kovacs A; Herold R; Osvath P; Simon M; Fekete S; Tenyi T
    Pharmacopsychiatry; 2009 Nov; 42(6):286-7. PubMed ID: 19924590
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.
    Chen SF; Shen YC; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):470-4. PubMed ID: 19302829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study.
    King D; Knapp M; Thomas P; Razzouk D; Loze JY; Kan HJ; van Baardewijk M
    Curr Med Res Opin; 2011 Feb; 27(2):365-74. PubMed ID: 21166610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient.
    Ittasakul P; Srivastava S; Hiranyatheb T; Ketter TA
    Asian J Psychiatr; 2012 Dec; 5(4):365-6. PubMed ID: 23174451
    [No Abstract]   [Full Text] [Related]  

  • 40. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.